"Array Suite 9.0 is a huge advancement in Omicsoft's product lines, including exciting new features for variant annotation, GWAS data analysis, and more",
Cary, NC (PRWEB) January 15, 2016
Omicsoft Corporation is excited to announce Array Suite 9.0, the latest release to its flagship software product, helping to accelerate bioinformatics research and cancer genomics. Array Suite provides the backbone of Omicsoft's software and data service offerings, including OncoLand, ImmunoLand, CVMLand, and GeneticsLand.
Array Suite 9.0 represents a full year of advancements, with new and updated features, helping to accelerate its customer's research in a variety of areas, including pharmacogenetics, Cancer Genomics, Immunology, and Cardiovascular and Metabolic disease areas. Omicsoft has taken a disease-centric approach to its software and data services, allowing its customers to focus on their disease areas of interest, while still enabling cross-disease research, and this latest release of Array Suite serves to enable this further.
This year's release includes a new variant annotation system, allowing users to upload their genetics data and comprehensively search, annotate, and filter using public domain resources. The variant annotation system provides the backbone of Omicsoft's GeneticsLand solution, allowing full analysis and management of GWAS and eQTL data types. The release also includes a wide range of new visualizations and analytics improvements and advancements for RNA-Seq, DNA-Seq, and clinical data management.
"Array Suite 9.0 is a huge advancement in Omicsoft's product lines, including exciting new features for variant annotation, GWAS data analysis, and more. I am very much looking forward to getting this in the hands of our customers, as we're very proud of our achievements over the past year," said Jack Liu, President of Omicsoft Corporation.
For more information, visit http://www.omicsoft.com.